Cargando…

Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma

The efficacy of sorafenib in combination with transarterial chemoembolization (TACE) or multiple-line therapies in patients with advanced hepatocellular carcinoma (HCC) remains unclear. This study aimed to investigate the overall survival (OS) of patients with advanced HCC in response to different c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsiao, Pojen, Hsieh, Kun-Chou, Chen, Yaw-Sen, Hsu, Chia-Chang, Lo, Gin-Ho, Li, Yu-Chan, Hsieh, Pei-Min, Lin, Hung-Yu, Wu, Tsung-Chin, Yeh, Jen-Hao, Lin, Chih-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636964/ https://www.ncbi.nlm.nih.gov/pubmed/31232945 http://dx.doi.org/10.1097/MD.0000000000016074

Ejemplares similares

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2020)

Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis
por: Chen, Yaw-Sen, et al.
Publicado: (2021)

Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis
por: Li, Yuan-Chen, et al.
Publicado: (2021)

Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis
por: Lin, Chih-Wen, et al.
Publicado: (2021)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
por: Lin, Chih-Wen, et al.
Publicado: (2018)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

NPRL2 down‐regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression
por: Wang, Ya‐Chin, et al.
Publicado: (2022)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection
por: Hsu, Chia‐Chang, et al.
Publicado: (2019)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
por: Huang, Song-Fong, et al.
Publicado: (2022)

Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
por: Lee, Chern-Horng, et al.
Publicado: (2023)

Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection
por: Lin, Chih-Wen, et al.
Publicado: (2018)

Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma
por: Yu, Ming-Chin, et al.
Publicado: (2021)

Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis
por: Liu, Chieh-Min, et al.
Publicado: (2021)

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels
por: Hsu, Po‐Yao, et al.
Publicado: (2021)

Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
por: Shueng, Pei-Wei, et al.
Publicado: (2011)

Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
por: Feng, Yu-Min, et al.
Publicado: (2015)

Spotted Temporal Lobe Necrosis following Concurrent Chemoradiation Therapy Using Image-Guided Radiotherapy for Nasopharyngeal Carcinoma
por: Chiang, Yu-Wei, et al.
Publicado: (2022)

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
por: Chiang, Hsueh-Chien, et al.
Publicado: (2023)

Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
por: Lai, You-Liang, et al.
Publicado: (2022)

Influences of Flipped Teaching in Electronics Courses on Students’ Learning Effectiveness and Strategies
por: Lo, Chih-Cheng, et al.
Publicado: (2021)

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer
por: Tsai, Mu-Hung, et al.
Publicado: (2022)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014)

Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib
por: Hsieh, Ming-Han, et al.
Publicado: (2020)

The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma
por: Lin, Chih-Wen, et al.
Publicado: (2017)

Primary hepatic carcinoid tumor: a case report and review of the literature
por: Lin, Chih-Wen, et al.
Publicado: (2009)

Effect of thalidomide on the expression of vascular endothelial growth factor in a rat model of liver regeneration
por: HUNG, KUO-CHEN, et al.
Publicado: (2013)

Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early–intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial
por: Lee, Teng-Yu, et al.
Publicado: (2017)

Sorafenib induces autophagy and suppresses activation of human macrophage
por: Lin, Jiunn-Chang, et al.
Publicado: (2013)

Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer
por: Hsieh, Chen-Hsi, et al.
Publicado: (2016)

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
por: Chuang, Min-Chun, et al.
Publicado: (2021)

Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer
por: Lee, Shu‐Hui, et al.
Publicado: (2019)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014)

Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
por: Fang, Yu-Hung, et al.
Publicado: (2019)

Robust combination of liver stereotactic body radiotherapy modulates pharmacokinetics of sorafenib toward preferable parameters
por: Hsieh, Chen-Hsi, et al.
Publicado: (2020)

Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report
por: Chen, Kuo-Hsin, et al.
Publicado: (2016)

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma
por: Wild, Aaron T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mgrcik45iq9io7tm3as8r52d4f